KMB

Business Context and Reporting Period

Company: Kimberly-Clark Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Business Overview: A global health and hygiene company operating in four segments: Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care. The company manufactures products such as diapers, tissue, and medical supplies sold under brands including Huggies, Kleenex, Scott, and Depend. Operations span 36 countries with products sold in over 150 countries.

Key Financial Metrics

Margins: Operating profit margin improved to 14.3% in 2007 from 12.5% in 2006. The effective income tax rate was 23.1% in 2007 compared to 25.4% in 2006.

Material Changes vs. Prior Period

• Revenue Growth: Driven by a 4% increase in sales volumes, 1% increase in net selling prices, 3% favorable currency effects, and 1% improved product mix.
• Profitability: Operating profit increased significantly due to lower charges for the Strategic Cost Reduction Plan ($377 million lower than 2006) and cost savings of approximately $265 million. These gains offset roughly $350 million in raw material cost inflation and a $50 million increase in strategic marketing expenses.
• Debt Structure: Long-term debt increased substantially following the issuance of $2.1 billion in notes in July 2007 to fund an Accelerated Share Repurchase (ASR) agreement and repay short-term credit facilities.
• Shareholder Returns: The company returned $3.7 billion to shareholders through dividends and share repurchases. In 2007, the company repurchased 41.2 million shares for approximately $2.8 billion.

Guidance, Outlook, and Risks

Outlook: Management expects top-line growth in 2008 consistent with long-term objectives, driven by momentum in the Personal Care segment and developing/emerging markets. The company intends to continue aggressive cost reduction and investment in innovation and marketing.

Strategic Cost Reduction Plan: The plan, initiated in 2005, aims to streamline manufacturing and administrative operations. Cumulative pretax charges are estimated at $880 million to $910 million by the end of 2008. The plan targets annual pretax savings of at least $350 million by 2009 and a net workforce reduction of approximately 10% (6,000 employees) by the end of 2008.

Risks and Contingencies:

• Raw Materials: Significant exposure to price fluctuations in pulp, petroleum-based materials, and energy. The company does not use derivatives to manage pulp or polypropylene price risks.
• Competition: Intense competition in global markets, particularly from private label products and consolidation among retailers, may pressure pricing and require increased promotional spending.
• Legal Proceedings: The company is involved in environmental litigation, including a dispute with the Delaware County Regional Water Quality Authority regarding effluent discharge. Management does not expect these matters to have a material adverse effect.
• Foreign Currency: A 10% unfavorable change in exchange rates could result in a net pretax loss of approximately $34 million on transactional exposures and reduce stockholders' equity by approximately $563 million on translation adjustments.

Investor Verification Checklist

• Raw Material Inflation: Verify the company's ability to pass on pulp and energy cost increases to consumers without losing market share.
• Cost Reduction Execution: Monitor the realization of the $350 million annual pretax savings target from the Strategic Cost Reduction Plan by 2009.
• Debt Servicing: Assess the impact of increased interest expense resulting from the $2.1 billion debt issuance on future cash flows.
• Segment Performance: Review the divergence in segment performance, specifically the 20% operating profit growth in Personal Care versus the 9.1% decline in Consumer Tissue.
• Share Repurchase Impact: Evaluate the sustainability of the aggressive share repurchase program ($2.8 billion in 2007) alongside capital spending and dividend obligations.